Clinical trial
Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease…
NCT00461942 · Xuanwu Hospital, Beijing, Other · Completed
Key facts
| NCT number | NCT00461942 |
|---|---|
| Title | Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease Patients |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Study to Assess the Neuroprotection Effect of Green Tea Polyphenol in De Novo Parkinson's Disease Patients |
| Lead sponsor | Xuanwu Hospital, Beijing, Other |
| Collaborators | Ministry of Health, China Michael J. Fox Foundation for Parkinson's Research |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Green Tea Polyphenols (EGCG/ECG) |
| Enrollment | 480 |
| Start date | Apr 1, 2006 |
| Completion | Mar 1, 2009 |
| First posted | Apr 18, 2007 |
| Last update posted | Aug 16, 2011 |
| Countries | China |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: